Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Agata Cieslak

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Oncotarget|September 23, 2015
RUNX1 as a recombinase cofactorAgata Cieslak, Dominique Payet-Bornet, Vahid Asnafi
British Journal of Haematology|October 13, 2015
NAP1L1-MLLT10 is a rare recurrent translocation that is associated with HOXA activation and poor treatment response in T-cell acute lymphoblastic leukaemiaJonathan Bond, Aurore Touzart, Agata Cieslak, et al.
Oncotarget|June 13, 2015
Targeting IRAK1 in T-cell acute lymphoblastic leukemiaCharles Dussiau, Amélie Trinquand, Ludovic Lhermitte, et al.
The Journal of Clinical Investigation|November 3, 2020
ALK-transformed mature T lymphocytes restore early thymus progenitor featuresAnnabelle Congras, Coralie Hoareau-Aveilla, Nina Caillet, et al.
Science Translational Medicine|December 4, 2024
RANKL treatment restores thymic function and improves T cell-mediated immune responses in aged miceJérémy C Santamaria, Jessica Chevallier, Léa Dutour, et al.
Haematologica|March 6, 2016
An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia studyJonathan Bond, Tony Marchand, Aurore Touzart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Clinical impact of NOTCH1 and/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphomaCeline Callens, Frederic Baleydier, Etienne Lengline, et al.
Blood Advances|January 4, 2018
Homeobox protein TLX3 activates miR-125b expression to promote T-cell acute lymphoblastic leukemiaLaurent Renou, Pierre-Yves Boelle, Caroline Deswarte, et al.
Blood|June 14, 2021
PRC2 loss of function confers a targetable vulnerability to BET proteins in T-ALLGuillaume P Andrieu, Milena Kohn, Mathieu Simonin, et al.
Blood|January 23, 2014
SET-NUP214 is a recurrent γδ lineage-specific fusion transcript associated with corticosteroid/chemotherapy resistance in adult T-ALLRaouf Ben Abdelali, Anne Roggy, Thibaut Leguay, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Oncotarget|September 23, 2015
RUNX1 as a recombinase cofactorAgata Cieslak, Dominique Payet-Bornet, Vahid Asnafi
British Journal of Haematology|October 13, 2015
NAP1L1-MLLT10 is a rare recurrent translocation that is associated with HOXA activation and poor treatment response in T-cell acute lymphoblastic leukaemiaJonathan Bond, Aurore Touzart, Agata Cieslak, et al.
Oncotarget|June 13, 2015
Targeting IRAK1 in T-cell acute lymphoblastic leukemiaCharles Dussiau, Amélie Trinquand, Ludovic Lhermitte, et al.
The Journal of Clinical Investigation|November 3, 2020
ALK-transformed mature T lymphocytes restore early thymus progenitor featuresAnnabelle Congras, Coralie Hoareau-Aveilla, Nina Caillet, et al.
Science Translational Medicine|December 4, 2024
RANKL treatment restores thymic function and improves T cell-mediated immune responses in aged miceJérémy C Santamaria, Jessica Chevallier, Léa Dutour, et al.
Haematologica|March 6, 2016
An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia studyJonathan Bond, Tony Marchand, Aurore Touzart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Clinical impact of NOTCH1 and/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphomaCeline Callens, Frederic Baleydier, Etienne Lengline, et al.
Blood Advances|January 4, 2018
Homeobox protein TLX3 activates miR-125b expression to promote T-cell acute lymphoblastic leukemiaLaurent Renou, Pierre-Yves Boelle, Caroline Deswarte, et al.
Blood|June 14, 2021
PRC2 loss of function confers a targetable vulnerability to BET proteins in T-ALLGuillaume P Andrieu, Milena Kohn, Mathieu Simonin, et al.
Blood|January 23, 2014
SET-NUP214 is a recurrent γδ lineage-specific fusion transcript associated with corticosteroid/chemotherapy resistance in adult T-ALLRaouf Ben Abdelali, Anne Roggy, Thibaut Leguay, et al.
Pageof 3